UP!

CNC $55.41   View long term graphs

Centene Corporation
Type
Public
Traded as NYSE: CNC
S&P 500 Component
Industry Healthcare
Founded 1984
Headquarters St. Louis, MO, U.S.
Revenue Increase US$ 40.60 billion (2016)
Operating income
Increase US$ 558 million (2016)
Net income
Increase US$ 562 million (2016)
Total assets Increase US$ 20.20 billion (2016)
Number of employees
30,500 (2016)
Website www.centene.com

Centene Corporation is a large publicly-traded company and a leading multi-line healthcare enterprise that serves as a major intermediary for both government-sponsored and privately-insured health care programs. The main lines of Centene include Medicare, Medicaid, The Health Insurance Marketplace System, (via the ACA), Tricare, as well as traditional commercial insurance. It is the second-largest publicly-traded corporation in the state of Missouri.

Centene also contracts with other healthcare and commercial organizations to provide specialty services, including behavioral health care services, case management software, correctional insurance, in-home health services, life and health management, vision, pharmacy benefits management, and telehealth services.

Founded as a single health plan in Wisconsin in 1984, Centene has established itself as a national leader in healthcare services. Chairman, President and CEO Michael F. Neidorff joined the company in 1996.

Over the past 33 years, Centene has grown to become a $40 billion member of the Fortune 500 trading on the New York Stock Exchange. With over 31,000 employees across the country, Centene operates health plans that serve 12.3 million members in 29 states and 2 international markets and offers a full range of health insurance solutions to other healthcare and commercial organizations.

July 2, 2015, Centene announced it would acquire Health Net. At announcement, it was estimated Health Net shareholders would own 29% of the combined company. March 2016, the merger was finalized and Health Net shareholders received 0.622 shares of Centene common stock and $28.25 in cash for each share at closing, making the total transaction value about $6 billion, including assumption of debt. After its acquisition of Health Net, Centene now provides healthcare to over 11 million people.

Centene currently ranks #66 on the Fortune 500 & #244 on the Fortune Global 500 List." On September 12, 2017, it was announced that Centene Corp. would acquire the nonprofit insurer Fidelis Care for US $3.75 billion.

Centene's health plans provide education and outreach programs.

In 2014, Superior HealthPlan of Texas was alleged to have denied coverage of an infant's surgery for brain cancer at Texas Children's Hospital where it has been alleged to have previously paid claims for the infant. Part of the source of the controversy lies in reports that that facility has a notably higher survival rate for such operations. Superior HealthPlan claims that it does not cover Texas Children's Hospital and that it has directed the family to a different facility. Superior HealthPlan said it was "confident" the family would find capable in-network providers.

News

Q reports

Period Date Adjusted Actuals EPS GAAP EPS
Q4 2020 2021-02-02 Future report Set alerts
Q3 2020 2020-10-27 Future report Set alerts
Q2 2020 2020-07-28 2.40 2.05
Q1 2020 2020-04-28 0.86 0.08
Q4 2019 2020-02-04 0.73 0.49
Q3 2019 2019-10-22 0.96 0.23
Q2 2019 2019-07-23 1.34 1.18
Q1 2019 2019-04-23 1.39 1.24
Q4 2018 2019-02-05 0.69 0.57
Q3 2018 2018-10-23 0.90 0.05

Ratings

2016-06-29 Upgrade Morgan Stanley Equal Weight to Overweight $84.00 to $86.00
2016-06-28 Initiated Coverage Wolfe Research Market Perform $80.00
2016-06-28 Reiterated Rating Credit Suisse Buy
2016-06-28 Reiterated Rating Credit Suisse Group AG Buy
2016-06-20 Reiterated Rating Cowen and Company Buy
2016-06-20 Reiterated Rating Wells Fargo Buy
2016-06-20 Reiterated Rating Leerink Swann Outperform $78.00 to $80.00
2016-06-20 Reiterated Rating Oppenheimer Outperform $89.00
2016-06-20 Reiterated Rating FBR & Co. Buy
2016-06-20 Upgrade Barclays Equal Weight to Overweight $76.00 to $82.00
2016-06-20 Reiterated Rating Wells Fargo & Co. Buy
2016-06-20 Reiterated Rating Oppenheimer Holdings Inc. Outperform $89.00
2016-06-20 Reiterated Rating FBR & Co Buy
2016-06-20 Upgrade Barclays PLC Equal Weight to Overweight $76.00 to $82.00
2016-06-16 Initiated Coverage Sanford C. Bernstein Underperform to Market Perform $76.00
2016-06-08 Reiterated Rating Jefferies Group Buy $80.00
2016-06-04 Reiterated Rating Cantor Fitzgerald Buy
2016-06-01 Boost Price Target Barclays Equal Weight $70.00 to $72.00
2016-05-26 Upgrade Stifel Nicolaus Hold to Buy $75.00
2016-05-24 Reiterated Rating Oppenheimer Buy $89.00
2016-05-12 Reiterated Rating Leerink Swann Buy
2016-04-29 Reiterated Rating Wedbush Outperform $80.00
2016-04-27 Reiterated Rating Cantor Fitzgerald Buy
2016-04-27 Reiterated Rating Morgan Stanley Hold
2016-04-25 Initiated Coverage Cowen and Company Outperform $70.00
2016-04-05 Reiterated Rating Jefferies Group Buy $80.00
2016-04-02 Reiterated Rating Citigroup Inc. Buy
2016-03-28 Boost Price Target Credit Suisse $70.00 to $72.00
2016-03-24 Boost Price Target Credit Suisse Neutral to Outperform $102.00 to $118.00
2016-03-24 Reiterated Rating Oppenheimer Buy $89.00
2016-02-11 Reiterated Rating Oppenheimer Outperform $89.00
2016-02-11 Reiterated Rating FBR & Co. Outperform $90.00
2016-02-11 Reiterated Rating Wedbush Outperform $80.00
2016-02-10 Lower Price Target Barclays Equal Weight $72.00 to $64.00
2016-02-09 Reiterated Rating Cantor Fitzgerald Buy $90.00
2016-01-27 Reiterated Rating Oppenheimer Outperform $89.00
2016-01-26 Reiterated Rating FBR & Co. Outperform
2016-01-08 Reiterated Rating Jefferies Group Buy $75.00 to $80.00
2016-01-06 Boost Price Target Barclays Equal Weight $70.00 to $72.00
2015-12-29 Reiterated Rating Cantor Fitzgerald Buy
2015-12-23 Reiterated Rating Cantor Fitzgerald Buy $90.00
2015-12-22 Boost Price Target Credit Suisse Outperform $65.00 to $79.00
2015-12-21 Reiterated Rating FBR & Co. Buy $90.00
2015-12-21 Boost Price Target Leerink Swann Outperform $75.00 to $78.00
2015-12-21 Boost Price Target Jefferies Group Buy $73.00 to $75.00
2015-12-21 Boost Price Target Citigroup Inc. Buy $72.00 to $76.00
2015-12-17 Reiterated Rating Cantor Fitzgerald Buy $85.00
2015-12-16 Initiated Coverage Credit Suisse Outperform $65.00
2015-12-15 Reiterated Rating Jefferies Group Buy $88.00 to $73.00
2015-10-28 Lower Price Target Barclays Equal Weight $81.00 to $70.00
2015-10-19 Reiterated Rating Oppenheimer Outperform $89.00
2015-10-02 Reiterated Rating Cantor Fitzgerald Buy $85.00
2015-10-02 Initiated Coverage Citigroup Inc. Buy $65.00
2015-07-29 Reiterated Rating Cantor Fitzgerald Buy $85.00
2015-07-29 Reiterated Rating Oppenheimer Outperform $89.00
2015-07-21 Downgrade Goldman Sachs Neutral to Sell $73.00 to $69.00
2015-07-21 Downgrade Goldman Sachs Group Inc. Neutral to Sell $73.00 to $69.00
2015-07-15 Upgrade Jefferies Group Hold to Buy $88.00
2015-07-14 Reiterated Rating Cantor Fitzgerald Buy
2015-07-13 Upgrade FBR & Co. Market Perform to Outperform $80.00 to $90.00
2015-07-08 Upgrade Wells Fargo & Co. Market Perform to Outperform
2015-07-08 Upgrade Wells Fargo Market Perform to Outperform
2015-07-06 Reiterated Rating Oppenheimer Outperform $89.00
2015-07-06 Reiterated Rating Cantor Fitzgerald Buy $85.00
2015-07-06 Downgrade Barclays Overweight to Equal Weight $88.00 to $81.00
2015-07-02 Reiterated Rating Barclays Overweight to Overweight $84.00 to $88.00
2015-06-22 Boost Price Target Oppenheimer Outperform $83.00 to $89.00
2015-06-15 Set Price Target Cantor Fitzgerald Buy $80.00 to $85.00
2015-06-15 Boost Price Target Deutsche Bank Hold $65.00 to $73.00
2015-06-15 Reiterated Rating Susquehanna Positive $85.00 to $87.00
2015-06-15 Reiterated Rating Wedbush Outperform $80.00 to $84.00
2015-06-15 Boost Price Target Leerink Swann Outperform $75.00 to $85.00
2015-06-15 Boost Price Target Barclays Overweight $84.00 to $88.00
2015-06-15 Boost Price Target Jefferies Group Hold $71.00 to $75.00
2015-06-15 Boost Price Target FBR & Co. Market Perform $75.00 to $80.00
2015-06-15 Boost Price Target Deutsche Bank AG Hold $65.00 to $73.00
2015-06-12 Reiterated Rating Oppenheimer Outperform $76.00 to $83.00
2015-05-13 Reiterated Rating Deutsche Bank Hold $65.00
2015-05-04 Reiterated Rating BMO Capital Markets Outperform $77.00 to $78.00
2015-04-29 Set Price Target Cantor Fitzgerald Buy $70.00 to $80.00
2015-04-28 Boost Price Target FBR & Co. Market Perform $55.00 to $75.00
2015-04-16 Boost Price Target Oppenheimer Outperform $63.00 to $76.00
2015-03-20 Boost Price Target Barclays Overweight $66.00 to $84.00
2015-02-25 Set Price Target Cantor Fitzgerald Buy $70.00
2015-02-24 Lower Price Target Barclays Overweight $132.00 to $66.00
2015-02-04 Reiterated Rating Deutsche Bank Hold $112.00 to $114.00
2015-02-04 Set Price Target Oppenheimer Buy $125.00
2015-02-04 Boost Price Target Wedbush Outperform $119.00 to $125.00
2015-01-26 Set Price Target Wedbush Buy $119.00
2015-01-08 Boost Price Target Barclays Overweight $120.00 to $132.00
2015-01-06 Reiterated Rating Deutsche Bank Hold $105.00 to $112.00
2015-01-06 Upgrade BMO Capital Markets Market Perform to Outperform $103.00 to $118.00
2014-12-16 Boost Price Target Credit Suisse Outperform $102.00 to $118.00
2014-12-15 Boost Price Target Deutsche Bank Hold $83.00 to $105.00
2014-12-15 Boost Price Target Bank of America Buy $114.00 to $120.00
2014-12-15 Boost Price Target Jefferies Group Hold $86.00 to $102.00
2014-12-15 Boost Price Target Barclays Overweight $102.00 to $120.00
2014-12-15 Boost Price Target RBC Capital Outperform $103.00 to $114.00
2014-12-15 Boost Price Target Bank of America Corp. Buy $114.00 to $120.00
2014-12-15 Boost Price Target Royal Bank Of Canada Outperform $103.00 to $114.00
2014-11-18 Reiterated Rating Bank of America Buy $104.00 to $114.00
2014-11-13 Downgrade FBR & Co. Outperform to Market Perform $90.00
2014-10-30 Reiterated Rating Credit Suisse Outperform $90.00 to $102.00
2014-10-29 Boost Price Target Oppenheimer Outperform $93.00 to $99.00
2014-10-29 Reiterated Rating Deutsche Bank Hold $77.00 to $83.00
2014-10-29 Reiterated Rating Barclays Overweight $96.00 to $102.00
2014-10-28 Reiterated Rating Citigroup Inc. Sell $69.00 to $71.00
2014-07-31 Boost Price Target Cantor Fitzgerald Buy $80.00 to $85.00
2014-07-29 Boost Price Target JPMorgan Chase & Co. Neutral $71.00 to $78.00
2014-07-25 Downgrade Wells Fargo & Co. Outperform to Market Perform
2014-07-25 Downgrade Wells Fargo Outperform to Market Perform
2014-07-23 Boost Price Target Barclays Overweight $84.00 to $96.00
2014-07-23 Reiterated Rating Citigroup Inc. Outperform $83.00 to $90.00
2014-07-23 Reiterated Rating S&P Equity Research Buy $89.00 to $94.00
2014-07-23 Boost Price Target Oppenheimer Outperform $89.00 to $93.00
2014-07-23 Boost Price Target Jefferies Group Hold $72.00 to $82.00
2014-07-22 Boost Price Target FBR & Co. Outperform $78.00 to $90.00
2014-07-16 Reiterated Rating Deutsche Bank Hold $70.00 to $74.00
2014-07-14 Boost Price Target Susquehanna $85.00 to $88.00
2014-06-27 Initiated Coverage Morgan Stanley Buy $87.00
2014-06-27 Initiated Coverage Sterne Agee CRT Positive to Buy $74.27 to $87.00
2014-06-26 Boost Price Target Oppenheimer Outperform $81.00 to $89.00
2014-06-16 Reiterated UBS Buy $73 to $79
2014-06-16 Boost Price Target Oppenheimer Outperform $78.00 to $81.00
2014-06-16 Reiterated Rating Credit Suisse Outperform $72.00 to $83.00
2014-06-16 Reiterated Rating JPMorgan Chase & Co. Neutral $69.00 to $71.00
2014-06-16 Boost Price Target Susquehanna $80.00 to $85.00
2014-06-03 Downgrade Citigroup Inc. Neutral to Sell $65.00
2014-05-19 Reiterated FBR Capital Outperform $70 to $78
2014-05-19 Boost Price Target FBR & Co. Outperform $70.00 to $78.00
2014-04-25 Reiterated Rating Cantor Fitzgerald Buy $73.00 to $80.00
2014-04-23 Reiterated Rating Deutsche Bank Hold $67.00
2014-04-23 Reiterated Rating Citigroup Inc. Hold $65.00
2014-04-23 Boost Price Target Oppenheimer $75.00 to $78.00
2014-04-23 Boost Price Target Leerink Swann Outperform $71.00 to $78.00
2014-04-23 Boost Price Target Jefferies Group Hold $65.00 to $69.00
2014-04-10 Boost Price Target Susquehanna Positive $68.00 to $70.00
2014-02-05 Boost Price Target Leerink Swann $68.00 to $71.00
2014-02-05 Upgrade Citigroup Inc. Sell to Neutral $59.00
2014-01-23 Upgrade Credit Suisse Neutral to Outperform $72.00 to $70.00
2013-12-16 Reiterated Rating Deutsche Bank Hold $71.00 to $67.00
2013-12-16 Upgrade Susquehanna Neutral to Positive $60.00 to $68.00
2013-11-21 Initiated Coverage Morgan Stanley Equal Weight
2013-11-18 Initiated Coverage Leerink Swann Outperform $68.00
2013-11-13 Initiated Coverage FBR & Co. Outperform $70.00
2013-10-27 Reiterated Rating BMO Capital Markets Buy $84.00
2013-10-23 Boost Price Target Jefferies Group Hold $66.00 to $68.00
2013-10-23 Boost Price Target Cantor Fitzgerald Buy $65.00 to $73.00
2013-10-23 Boost Price Target BMO Capital Markets Market Perform $56.00 to $62.00
2013-10-23 Boost Price Target Barclays Overweight $68.00 to $84.00
2013-10-23 Downgrade Monness Crespi & Hardt Buy to Neutral $70.00
2013-10-23 Downgrade Citigroup Inc. Neutral to Sell
2013-10-16 Boost Price Target Deutsche Bank Hold $63.00 to $71.00
2013-10-09 Reiterated Rating Susquehanna Neutral $55.00 to $60.00
2013-10-08 Reiterated Rating JPMorgan Chase & Co. Hold $60.00
2013-10-08 Boost Price Target Deutsche Bank Hold $55.00 to $63.00
2013-09-24 Reiterated Rating Jefferies Group Hold $63.00
2013-09-24 Boost Price Target JPMorgan Chase & Co. Neutral $50.00 to $60.00
2013-09-16 Reiterated Rating Wedbush Buy $67.00
2013-09-16 Boost Price Target Jefferies Group Hold $63.00
2013-07-23 Upgrade Cantor Fitzgerald Hold to Buy $50 to $65
2013-05-30 Reiterated Monness Crespi & Hardt Buy $54 to $60
2013-04-23 Reiterated Cantor Fitzgerald Hold $45 to $50
2013-02-05 Reiterated Cantor Fitzgerald Hold $32 to $45
2013-01-04 Reiterated Barclays Overweight $51 to $60
2012-12-17 Reiterated Deutsche Bank Hold $40 to $38
2012-12-03 Reiterated Barclays Overweight $47 to $51
2016-06-29 Upgrade Morgan Stanley Equal Weight to Overweight $84.00 to $86.00
2016-06-28 Initiated Coverage Wolfe Research Market Perform $80.00
2016-06-28 Reiterated Rating Credit Suisse Buy
2016-06-28 Reiterated Rating Credit Suisse Group AG Buy
2016-06-20 Reiterated Rating Cowen and Company Buy

There is presents forecasts of rating agencies and recommendations for investors about this ticker

Major Shareholders

Name Relationship Total Shares Holding stocks
NEIDORFF MICHAEL F Chairman, President and CEO 6.19%  (3625571) BWS / CNC /
DITMORE ROBERT K 0.81%  (471917) CNC /
Hunter Jesse N EVP, Chief Bus. Dev. Officer 0.40%  (233629) CNC /
Thompson Tommy G 0.32%  (187914) BCR / CGIX / CNC / CYTX / DOC / PURE / TXMD / UTHR /
BRINKLEY CYNTHIA J EVP, International Operations 0.28%  (163694) CNC /
EPPINGER FREDERICK H 0.27%  (158737) CNC / STC / THG /
Imholz Donald G EVP, Chief Information Officer 0.26%  (151599) CNC /
JOSEPH PAMELA A 0.24%  (140534) CNC / PAYX / TSS / USB /
SCHEFFEL WILLIAM N Exec VP, CFO & Treasurer 0.24%  (138362) CNC /
Schwaneke Jeffrey A. SVP, Corp. Controller & CAO 0.23%  (132632) CNC /
ROBERTS JOHN R 0.18%  (106913) CNC / ENR /
STEWARD DAVID L 0.18%  (104021) CNC /
Baldwin Kenneth Rone EVP, Insurance Group 0.16%  (92712) CNC /
Williamson Keith H EVP, Secr. & General Counsel 0.16%  (92658) CNC / PPL /
AYALA ORLANDO 0.16%  (92165) CNC /
GOLDMAN CAROL Exec VP Chief Admin Officer 0.12%  (70876) CNC /
BOWERS CHRISTOPHER D EVP, Markets 0.11%  (65908) CNC /
BROOKS MARK J SVP, Chief Information Officer 0.08%  (48915) CNC /
KROLL EDMUND E SVP Fin & Investor Relations 0.08%  (46279) CNC /
HARROLD JASON M EVP, Specialty Comp. Bus. Unit 0.08%  (44329) CNC /
GEPHARDT Richard A 0.07%  (42623) CNC / CTL / F / SPR / X /
HITCHCOCK ROBERT T EVP Health Plans 0.05%  (26415) CNC /
MINIFIE C DAVID EVP, Chief Marketing Officer 0.04%  (24031) CNC /
ESCARRA VICKI B 0.03%  (15035) CNC / HNT /
Isaak Christopher R SVP, Corporate Controller, CAO 0.02%  (14393) CNC / VIAS /

Comments